We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.62%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.4B
AUM Growth
+$6.86B
(+9.1%)
Cap. Flow
+$638M
Cap. Flow
% of AUM
0.77%
Top 10 Holdings %
Top 10 Hldgs %
14.3%
Holding
1,037
New
122
Increased
448
Reduced
276
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$390M |
| 2 |
Ambev
ABEV
|
+$272M |
| 3 |
GE Aerospace
GE
|
+$244M |
| 4 |
Intuitive Surgical
ISRG
|
+$208M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$181M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$433M |
| 2 |
Microsoft
MSFT
|
+$293M |
| 3 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$284M |
| 4 |
Qualcomm
QCOM
|
+$272M |
| 5 |
United Parcel Service
UPS
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.23% |
| 2 | Financials | 14.08% |
| 3 | Communication Services | 12.37% |
| 4 | Healthcare | 11.68% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Core Laboratories
CLB
$538M
| $6.02M | 0.01% |
+31,550
| New | +$5.87M |
|
802
Cooper Companies
COO
$13.7B
| $6.01M | 0.01% |
194,000
-1,862,132
| -91% | -$59.4M |
|
803
Domino's
DPZ
$11B
| $5.96M | 0.01% |
85,600
+4,210
| +5% | +$288K |
|
|
ROIC
804
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $5.92M | 0.01% |
402,027
| – | – |
|
|
DO
805
DELISTED
Diamond Offshore Drilling
DO
| $5.91M | 0.01% |
103,840
+28,660
| +38% | +$1.73M |
|
806
Zillow
ZG
$7.02B
| $5.91M | 0.01% |
216,870
-571,530
| -72% | -$15.1M |
|
|
KMI.WS
807
DELISTED
Kinder Morgan Inc
KMI.WS
| $5.85M | 0.01% |
1,440,000
| – | – |
|
808
Standard BioTools
LAB
$326M
| $5.83M | 0.01% |
+152,149
| New | +$4.48M |
|
809
Paychex
PAYX
$40.4B
| $5.76M | 0.01% |
126,530
+6,460
| +5% | +$276K |
|
|
DOC
810
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.74M | 0.01% |
450,220
+240,740
| +115% | +$2.97M |
|
811
CNX Resources
CNX
$4.85B
| $5.72M | 0.01% |
180,540
-90,000
| -33% | -$2.75M |
|
812
PG&E
PCG
$47.8B
| $5.67M | 0.01% |
140,743
-778,850
| -85% | -$31.9M |
|
813
Methanex
MEOH
$4.32B
| $5.63M | 0.01% |
+95,060
| New | +$5.48M |
|
|
AEC
814
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $5.61M | 0.01% |
+349,420
| New | +$5.39M |
|
815
Hormel Foods
HRL
$13.9B
| $5.42M | 0.01% |
240,180
+5,460
| +2% | +$120K |
|
816
Essent Group
ESNT
$6.06B
| $5.42M | 0.01% |
+225,270
| New | +$4.94M |
|
|
XEC
817
DELISTED
CIMAREX ENERGY CO
XEC
| $5.36M | 0.01% |
+51,100
| New | +$5.17M |
|
|
FTD
818
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $5.29M | 0.01% |
+162,219
| New | +$5.26M |
|
|
VVC
819
DELISTED
Vectren Corporation
VVC
| $5.26M | 0.01% |
148,272
-24,760
| -14% | -$855K |
|
|
CSII
820
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.16M | 0.01% |
+150,512
| New | +$4.38M |
|
|
CBL
821
DELISTED
CBL& Associates Properties, Inc.
CBL
| $5.11M | 0.01% |
284,580
-179,000
| -39% | -$3.36M |
|
822
Southern Company
SO
$110B
| $5.09M | 0.01% |
+123,725
| New | +$5.11M |
|
823
Performance Shipping
PSHG
$22.1M
| – | – |
0
| – | – |
|
824
News Corp Class A
NWSA
$14.5B
| $4.94M | 0.01% |
274,038
+67,376
| +33% | +$1.16M |
|
825
HSBC
HSBC
$355B
| $4.93M | 0.01% |
103,754
-1,149
| -1% | -$54.4K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2013 Portfolio in Review
As of Q4 2013, OppenheimerFunds held 1,037 positions worth $82.4B, up 9.1% from $75.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q4 2013 filing shows 122 new, 448 increased, 276 reduced and 133 closed positions. Its largest new stake was Ambev: 37,192,110 shares worth $273M. The largest sale was IBM, an estimated $433M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 17% a quarter earlier, followed by Financials and Communication Services.
- OppenheimerFunds's largest Q4 2013 buy was Ambev: 37,192,110 shares worth $273M.
- OppenheimerFunds added most to Allergan plc in Q4 2013, an estimated $390M increase.
- OppenheimerFunds's biggest Q4 2013 reduction was Microsoft, cutting an estimated $293M.
- OppenheimerFunds fully exited IBM in Q4 2013, selling an estimated $433M.
- OppenheimerFunds's ten largest holdings make up 14% of its $82.4B portfolio in Q4 2013.
- OppenheimerFunds opened 122 new positions and closed 133 in Q4 2013.
- OppenheimerFunds's portfolio value rose 9.1% quarter-over-quarter to $82.4B.
Based on OppenheimerFunds's 13F filing for Q4 2013, filed 12 Feb 2014.